CANCER News & Analysis

Bristol-Myers Squibb Co says it will buy Celgene Corp for about $105bn, combining two of the world's largest cancer drug businesses in the biggest...

A pipeline of blockbuster products will help the household-name healthcare brand withstand a baby powder asbestos scare that has buffeted its share...